The shares of an orthopedic medical device company that features personalized knee and hip replacement products, Conformis Inc. (CFMS) have risen 12.20% to $1.84 at the last check in after-hours trading on Tuesday. CFMS stock gained 4.46% to $1.64 at the end of the regular session. Conformis stock traded in a range of $1.57 to $1.69.

On average, CFMS stock traded 2.87 million shares per day over the past 100 days, so the volume of 5.7 million shares traded on the day was above that average. In the past five days, Conformis shares have increased by 11.56%, while in the past month; they have increased by 56.79%. Conformis stock rose in the absence of current news, so recent developments can be cited to provide a better understanding of the company.

How did things go at CFMS Stock recently?

Conformis is a medical technology company that develops, manufactures, and sells joint replacement implants and instruments based on its proprietary iFit technology platform. In addition to customizing their products to fit and conform to each patient’s unique anatomy, CFMS calls their products personalized, individualized, or sometimes customized.

A comprehensive line of sterile, personalized knee and hip implants as well as single-use surgical instruments is available through CFMS. All major joints are covered by Conformis by its issued patents or exclusive licensed patent applications for implants and instrumentation adapted to the patient’s anatomy.

In recent news, Conformis announced that it’s Chief Executive Officer Mark Augusti and Chief Financial Officer Bob Howe will participate in the 40th annual Canaccord Genuity Growth Conference.

• A virtual presentation by CFMS will be held on Wednesday, August 11, 2021 at 4:00 p.m. ET.
• CFMS presentation can be streamed live at https://wsw.com/webcast/canaccord60/cfms/2438788.
• There will also be one-on-one meetings available throughout the conference with CFMS management.
• A live webcast of the presentation can be viewed on the Investors page of the CFMS website under “Events and Presentations”.
• CFMS will archive the webcast for 30 days following the presentation on its website.
• Moreover, a settlement between Conformis and Stryker Corporation regarding the Wright Medical Technology, Inc. and Tornier, Inc. (collectively, “Wright Medical”) patent litigation was announced last month.
• Wright Medical, acquired by Stryker in November 2020, was sued by CFMS on April 24, 2020, in United States District Court for the District of Delaware.
• The amended complaint asserted that Wright Medical’s specialized shoulder instruments, and the implants they use, infringed certain Conformis patents.

How the matter will be settled?

The settlement emphasizes CFMS’ strong and valuable intellectual property, as well as its commitment to safeguarding and enforcing it. Stryker will make a one-time payment to Conformis (CFMS) and receive a nonexclusive license for some Conformis patents as part of the settlement.